TRACE Study
Transfer of multivirus-specific T cells following transplantation: TRACE Study
The “TRACE” project is a multi-national project (Belgium, France, Germany, Italy, the Netherlands, UK) and was coordinated for a long time by the LMU Munich, Germany. The overall objective of the TRACE project is to bring Adoptive Transfer of virus-specific T cells into clinical routine, thereby facilitating that every single patient in Europe will have the possibility to receive this curative treatment.
This project is funded by the European Commission within Horizon2020 Framework Programme.
For more details see:
The Consortium consists of Partners from Basic, clinical and industrial Research and GMP-facilities (Good Manufacturing Practice laboratory), with proven qualification and leading Expertise in the field of HSCT (Haematopoietic Stem Cell Transplantation), GMP-manufacturing and adoptive T-cell tansfer. Impact and Exploration will reach beyond refractory viral infections post HSCT.
Medical Center - University of Freiburg, UKF, Freiburg, Deutschland (Koordinator)
Ospedale Pediatrico Bambino Gesù, OPBG, Rom, Italien
Leiden University Medical Centre, LUMC, Leiden, Niederlande
Centre Hospitalier Universitaire de Nancy, CHU, Vandoeuvre-Lès-Nancy, Frankreich
Universitätsklinik Gent, UZG, Gent, Belgien
Ludwig-Maximilians-Universität, LMU, München, Deutschland
Miltenyi Biotec GmbH, MILTENYI, Bergisch-Gladbach, Deutschland